CAMP4 Therapeutics Stock (NASDAQ:CAMP)


ForecastOwnershipChartTranscripts

Previous Close

$5.06

52W Range

$3.50 - $12.30

50D Avg

$6.22

200D Avg

$7.49

Market Cap

$100.40M

Avg Vol (3M)

$108.41K

Beta

1.76

Div Yield

-

CAMP Company Profile


CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

58

IPO Date

Oct 11, 2024

Website

CAMP Performance


Latest Earnings Call Transcripts


Q3 24Jan 09, 24 | 6:33 PM
Q2 24Oct 05, 23 | 6:53 PM
Q1 24Jul 10, 23 | 7:24 PM

Peer Comparison


TickerCompany
DGIIDigi International Inc.
CMTLComtech Telecommunications Corp.
ADTNADTRAN Holdings, Inc.
ITRNIturan Location and Control Ltd.
KVHIKVH Industries, Inc.
KNKnowles Corporation
HLITHarmonic Inc.
MYNAMynaric AG
NTGRNETGEAR, Inc.
COMMCommScope Holding Company, Inc.
FEIMFrequency Electronics, Inc.
TSATTelesat Corporation
AVNWAviat Networks, Inc.